Kurt Schrader: “That prescription drug bill is an excellent, excellent balance between H.R. 3 and what others would perhaps like to do.”

The success that WRDA has had during these divided times is a testament to the committee's willingness to work across the aisle.

I want that to occur in America. I want it to occur in the districts that some of these members in this room represent, and I think we found that balance.

The BIOSIM Act is a commonsense approach to increase the utilization of biosimilars in this country.

The absence of a long-term sustainable funding source for the Highway Trust Fund is deeply concerning.